ShockWave Medical, Inc.

NASDAQ:SWAV

334.75 (USD) • At close May 30, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Revenue 730.23489.733237.14667.78942.92712.2631.719
Cost of Revenue 95.38864.99641.43820.99117.1597.252.836
Gross Profit 634.842424.737195.70846.79825.7685.013-1.117
Gross Profit Ratio 0.8690.8670.8250.690.60.409-0.65
Reseach & Development Expenses 145.64781.67950.54436.92632.85322.69817.963
General & Administrative Expenses 95.26556.92934.74723.86314.1345.9795.422
Selling & Marketing Expenses 234.837161.995111.28851.67230.6217.5366.363
SG&A 323.202218.924146.03575.53544.75423.51511.785
Other Expenses 23.9621.055-0.5821.2562.3450.5890.366
Operating Expenses 468.849300.603196.579112.46177.60746.21329.748
Operating Income 165.993124.134-0.871-65.663-51.839-41.2-30.865
Operating Income Ratio 0.2270.253-0.004-0.969-1.208-3.36-17.955
Total Other Income Expenses Net 8.288-3.306-7.9640.0440.7920.5370.334
Income Before Tax 174.281120.828-8.835-65.619-51.047-41.064-30.589
Income Before Tax Ratio 0.2390.247-0.037-0.968-1.189-3.349-17.795
Income Tax Expense 27.003-95.1680.3010.080.0620.0380.026
Net Income 147.278215.996-9.136-65.699-51.109-41.102-30.615
Net Income Ratio 0.2020.441-0.039-0.969-1.191-3.352-17.81
EPS 4.016.02-0.26-1.99-2.14-1.53-1.57
EPS Diluted 3.855.7-0.26-1.99-2.14-1.53-1.57
EBITDA 176.351122.714-7.739-64.407-49.494-39.911-30.031
EBITDA Ratio 0.2420.251-0.033-0.95-1.153-3.255-17.47